• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAUSCH + LOMB AKREOS MICROINCISION IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAUSCH + LOMB AKREOS MICROINCISION IOL; INTRAOCULAR LENS Back to Search Results
Model Number MI60P
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Endophthalmitis (1835); Blurred Vision (2137); Eye Pain (4467)
Date of Event 09/25/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device remains implanted.A review of the lot device history record (dhr) did not identify any anomalies or non-conformities that could be related to this event.Based on the available information, the root cause of this event could not be determined.
 
Event or Problem Description
The healthcare facility reported that following an intraocular lens (iol) implantation in the right eye, the patient had pain and blurred vision.Two (2) days post procedure, the patient presented for emergency care at another healthcare facility with severe pain and symptoms of endophthalmitis.The patient was hospitalized and on the second day, a vitrectomy with silicone oil administration was performed.A microbiological culture identified enterococcus faecalis infection.Antibiotic therapy (including vancomycin) was initiated.Four (4) days post-secondary procedure, the patient was discharged from the hospital with preserved vision of 1/50, without pain and the iol remains implanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AKREOS MICROINCISION IOL
Common Device Name
INTRAOCULAR LENS
Manufacturer (Section D)
BAUSCH + LOMB
1400 north goodman street
rochester NY 14609
Manufacturer (Section G)
BAUSCH + LOMB, INC.
21 north park place blvd
clearwater FL 33759
Manufacturer Contact
shayan habibi
21 north park place blvd
clearwater, FL 33759
7277246600
MDR Report Key23435567
Report Number0001313525-2025-00198
Device Sequence Number15621294
Product Code HQL
UDI-Device Identifier10757770500762
UDI-Public(01)10757770500762(17)270630(11)240727(10)1Q19902
Combination Product (Y/N)N
Initial Reporter CountryPL
PMA/510(K) Number
P060022
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 10/01/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberMI60P
Device Catalogue NumberMI60P1750
Device Lot Number1Q19902
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/03/2025
Initial Report FDA Received Date10/31/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured07/27/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
AMVISC+, EYEFILHD, BSS, VISCOJECTINJ, CUSTOMPACK.
Outcome Attributed to Adverse Event Required Intervention;
Patient Age75 YR
Patient SexFemale
-
-